Status:
COMPLETED
Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate Cancer
Lead Sponsor:
Ankara Etlik City Hospital
Conditions:
Prostate Cancer
Prostate Adenocarcinoma
Eligibility:
MALE
45-75 years
Brief Summary
Recent guidelines now recommend multi parametric magnetic resonance imaging prior to biopsy for all men as an integral part of improved diagnosis of clinical significant prostate cancer. However, magn...
Eligibility Criteria
Inclusion
- Patients who all had undergone multi parametric magnetic resonance imaging at our hospital
- Patients who all had undergone transrectal ultrasonography guided cognitive and fusion targeted biopsies
Exclusion
- Magnetic resonance imaging at exterior hospitals
- Insufficient image quality/artifacts
- Previous prostate biopsy and/or prior prostate cancer diagnosis
Key Trial Info
Start Date :
January 12 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 16 2023
Estimated Enrollment :
616 Patients enrolled
Trial Details
Trial ID
NCT06029088
Start Date
January 12 2023
End Date
June 16 2023
Last Update
September 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara University School of Medicine
Ankara, Turkey (Türkiye), 06100